181 related articles for article (PubMed ID: 17174810)
1. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies.
Ben-Haim S; Kupzov E; Tamir A; Frenkel A; Israel O
J Nucl Cardiol; 2006 Nov; 13(6):791-800. PubMed ID: 17174810
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
Ben-Haim S; Kupzov E; Tamir A; Israel O
J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
[TBL] [Abstract][Full Text] [Related]
3. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
4. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.
Tatsumi M; Cohade C; Nakamoto Y; Wahl RL
Radiology; 2003 Dec; 229(3):831-7. PubMed ID: 14593193
[TBL] [Abstract][Full Text] [Related]
6. [Incidence of focal myocardial (18)F-FDG uptake and correlation with coronary calcifications by PET/CT].
Garcia JR; Soler M; Fuertes S; Riera E; Moreno A; Lomeña F; Carrio I
Rev Esp Med Nucl; 2011; 30(1):8-13. PubMed ID: 21208695
[TBL] [Abstract][Full Text] [Related]
7. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
8. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
9. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
[TBL] [Abstract][Full Text] [Related]
10. Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT.
Wassélius J; Larsson S; Jacobsson H
Ann Nucl Med; 2009 Jan; 23(1):59-64. PubMed ID: 19205839
[TBL] [Abstract][Full Text] [Related]
11. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG uptake and calcifications in the thoracic aorta on positron emission tomography/computed tomography examinations: frequency and stability on serial scans.
Meirelles GS; Gonen M; Strauss HW
J Thorac Imaging; 2011 Feb; 26(1):54-62. PubMed ID: 20562727
[TBL] [Abstract][Full Text] [Related]
13. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction.
Lee SJ; On YK; Lee EJ; Choi JY; Kim BT; Lee KH
J Nucl Med; 2008 Aug; 49(8):1277-82. PubMed ID: 18632820
[TBL] [Abstract][Full Text] [Related]
14. Prediction of coronary artery calcium progression by FDG uptake of large arteries in asymptomatic individuals.
Cho SG; Park KS; Kim J; Kang SR; Kwon SY; Seon HJ; Jabin Z; Kim YJ; Jeong GC; Song M; Song HC; Min JJ; Bom HS
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):129-140. PubMed ID: 27683281
[TBL] [Abstract][Full Text] [Related]
15. What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque.
Menezes LJ; Kayani I; Ben-Haim S; Hutton B; Ell PJ; Groves AM
Atherosclerosis; 2010 Jul; 211(1):136-40. PubMed ID: 20202634
[TBL] [Abstract][Full Text] [Related]
16. Association of vascular 18F-FDG uptake with vascular calcification.
Dunphy MP; Freiman A; Larson SM; Strauss HW
J Nucl Med; 2005 Aug; 46(8):1278-84. PubMed ID: 16085583
[TBL] [Abstract][Full Text] [Related]
17. A positron emission tomography/computed tomography (PET/CT) evaluation of asymptomatic abdominal aortic aneurysms: another point of view.
Palombo D; Morbelli S; Spinella G; Pane B; Marini C; Rousas N; Massollo M; Cittadini G; Camellino D; Sambuceti G
Ann Vasc Surg; 2012 May; 26(4):491-9. PubMed ID: 22197524
[TBL] [Abstract][Full Text] [Related]
18. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
[TBL] [Abstract][Full Text] [Related]
19. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
Rosen RS; Fayad L; Wahl RL
J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
